Royalty and Revenue-Share Investing in Private Companies

Not every private investment needs to be a bet on equity. Royalty and revenue-share investments give investors a percentage of a company's revenue, or of a specific product's sales, instead of ownership. Returns come from cash flows rather than a future exit.

The model ranges from large-scale pharmaceutical royalty investing, led by companies such as Royalty Pharma, to revenue-based financing for software and consumer startups, and to music and media royalties. This guide explains how royalty and revenue-share investing works, where it fits, and the trade-offs for investors and companies.

1. How It Works

• Investors provide capital to a company or buy an existing royalty stream.
• They receive a percentage of revenue, or of revenue from a specific product or asset.
• Payments continue until a set return, often a multiple of the original investment, is reached, or for a set period or the life of the asset.
• No ownership is usually acquired, so founders keep their equity.

2. Common Forms

• Revenue-based financing (RBF) for startups with recurring revenue, repaid through a share of monthly revenue until a cap is reached. See revenue-based financing vs. equity.
• Pharmaceutical and life sciences royalties, where investors buy rights to a share of sales of approved drugs, often from universities, research institutions or biotech companies.
• Music, film and media royalties, tied to streaming, licensing and performance revenue.
• Natural resource royalties, such as mining and energy.
• Franchise and brand royalties.

3. Why Investors Like It

• Earlier cash returns than equity, which may take years to exit.
• Less dependence on exits and valuation multiples.
• Priority over equity in some structures.
• Diversification across industries and cash flow sources.

4. Risks and Limitations

• Revenue decline. Payments fall if sales drop, and a failed product or company can mean losses.
• Capped upside. Unlike equity, returns are usually limited to a set multiple.
• Complex valuation, especially for long-lived royalties.
• Company default or restructuring, which can reduce or stop payments.
• Reporting reliance. Investors depend on accurate revenue reporting, making audit rights important.

5. Why Companies Use It

• Non-dilutive capital that preserves founder ownership.
• Flexible repayments that rise and fall with revenue.
• Faster funding than an equity round in many cases.
• Monetising future revenue, such as a university selling drug royalties to fund new research.

For more non-dilutive options, see non-dilutive funding options.

6. What Investors Should Check

1. Revenue quality, stability and concentration.
2. The repayment cap, percentage and term.
3. Audit and information rights.
4. Priority relative to other creditors and investors.
5. What happens in a sale or restructuring.

Frequently Asked Questions

Is revenue-based financing debt or equity?

It is usually treated as a form of financing that sits between debt and equity, with repayments tied to revenue rather than fixed instalments.

What returns do royalty investments offer?

They vary widely by asset type and risk. Capped structures limit upside but can deliver earlier and more predictable cash flows.

Can individual investors invest in royalties?

Some platforms offer access to music or revenue-share deals, and listed royalty companies are available on public markets.

What happens if the company fails?

Payments may stop, and recovery depends on the investor's position relative to other creditors.

The Bottom Line

Royalty and revenue-share investing offers cash-flow-based returns without equity ownership, suiting investors who want earlier income and companies that want non-dilutive capital. The trade-off is capped upside and direct exposure to revenue risk. See also litigation finance.

Global Capital Network connects investors and founders with alternative financing through our events and investor network. Get in touch to learn more.

This article is general information, not investment advice.